Enterome vs Sable Bio

Enterome vs Sable Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Sable Bio on 41/100.

Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome
Sable Bio logo
Sable BioAI drug safety startup
Try Sable Bio

Where each one leads

Enterome

  • our overall score: 60/100 against 41/100
  • domain rating: 46/100 against 14/100
  • funding raised: $124M against $3.1M

Sable Bio

  • agent readiness: 44/100 against 21/100

At a glance

MeasureEnteromeSable Bio
What it isClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.AI drug safety startup
CategoryBiotechnology, Drug Discovery, Oncology, ImmunotherapyBiotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformPlatform
Founded20122022
HeadquartersParis, FranceLondon, United Kingdom
StatusActiveActive

Size, funding and growth

MeasureEnteromeSable Bio
Employees33Not published
Total funding$124M$3.1M
Latest roundLater Stage VCUnknown
ValuationNot published$1.1B
LinkedIn followers16,846Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEnteromeSable Bio
StartupHub scoreOur 0-100 rating60/10041/100
Traction55/10032/100
Team70/100Not published
Search visibility34/10011/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (44/100)
Domain ratingLink authority, 0-10046/10014/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEnteromeSable Bio
HostingSelf ManagedNot detected
CMSWordPressFramer
FrameworksBootstrapNot detected
AnalyticsGoogle Analytics 4, SegmentGoogle Analytics 4

Enterome vs Sable Bio: common questions

Which is better, Enterome or Sable Bio?

On our 0-100 score Enterome rates higher (60/100 against 41/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do Enterome and Sable Bio compare on the numbers?

Enterome leads on our overall score (60/100 against 41/100), domain rating (46/100 against 14/100), funding raised ($124M against $3.1M). Sable Bio leads on agent readiness (44/100 against 21/100).

Read the full Enterome review and pricing or the Sable Bio review and pricing. You can also browse other Enterome alternatives we track.